Table 2.
Total n = 244 |
BKPyVAN n = 17 |
Non-BKPyVAN n = 227 |
|
---|---|---|---|
Urinary tract cancer | |||
Renal cell carcinoma | 3 | 1 | 2 |
Pelvis/ureter | 1 | 0 | 1 |
Bladder | 16 | 4 | 12 |
Prostate | 0 | 0 | 0 |
Total | 20 (8.2%) | 5 (29.4%) | 15 (6.6%) |
Other cancers | |||
Hepatocellular carcinoma | 2 | 0 | 2 |
Lymphoma | 2 | 0 | 2 |
Cervical cancer | 2 | 0 | 2 |
Endometrial cancer | 1 | 0 | 1 |
Breast cancer | 1 | 0 | 1 |
Colon cancer | 1 | 0 | 1 |
Lung cancer | 1 | 0 | 1 |
Kaposi sarcoma | 1 | 0 | 1 |
Total | 11 (4.5%) | 0 (0%) | 11 (4.8%) |